Letter to the Editor: Postdiagnosis Aspirin Use Associated With Decreased Biliary Tract Cancer?
- PMID: 34555199
- DOI: 10.1002/hep.32170
Letter to the Editor: Postdiagnosis Aspirin Use Associated With Decreased Biliary Tract Cancer?
Comment on
-
Postdiagnosis Aspirin Use Associated With Decreased Biliary Tract Cancer-Specific Mortality in a Large Nationwide Cohort.Hepatology. 2021 Oct;74(4):1994-2006. doi: 10.1002/hep.31879. Epub 2021 Jul 20. Hepatology. 2021. PMID: 33942350 Free PMC article.
References
-
- Liao SF, Koshiol J, Huang YH, Jackson SS, Huang YH, Chan C, et al. Postdiagnosis aspirin use associated with decreased biliary tract cancer‐specific mortality in a large nationwide cohort. Hepatology. 2021;74:1994–2006.
-
- Muangchan C, van Vollenhoven RF, Bernatsky SR, Smith CD, Hudson M, Inanç M, et al. Treatment algorithms in systemic lupus erythematosus. Arthritis Care Res. 2015;67:1237–45.
-
- McNellis RJ, Beswick‐Escanlar V. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer. Am Fam Physician. 2016;94:661–2.
-
- Veitch A, Vanbiervliet G, Gershlick A, Boustiere C, Baglin T, Smith LA, et al. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Endoscopy. 2016;48:385–402.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
